The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus

被引:19
作者
Lee, YH [1 ]
Rho, YH [1 ]
Choi, SJ [1 ]
Ji, JD [1 ]
Song, GG [1 ]
机构
[1] Korea Univ, Med Ctr, Dept Internal Med, Div Rheumatol,Coll Med, Seoul 136705, South Korea
关键词
p53; polymorphisms; systemic lupus erythematosus;
D O I
10.1191/0961203305lu2224oa
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study is to investigate whether the functional p53 codon 72 polymorphism is associated with susceptibility to SLE and its clinical features. A polymerase chain reaction of genomic DNA-restriction fragment length polymorphism was used to determine genotypes of the p53 codon 72 in 90 SLE patients and 114 healthy controls. Clinical/serological manifestations were analysed in each patient and correlated with the genotypes. The OR of the association of the Pro allele with SLE was 1.70 (95% Cl, 1.15-2.53, P = 0.0079) and the OR of the Pro/Pro (a recessive model) was significantly increased (OR = 2.58, 95% Cl = 1.24-5.39, P = 0.0093). The Armitage's trend test indicated a significant dosage effect of the Pro allele for SLE (OR = 1.73, chi-square = 7.08, P = 0.0078). However, there was no significant association of the polymorphism with clinical/serological manifestations studied here. In conclusion, our finding suggests the functional p53 codon 72 polymorphism may be associated with SLE susceptibility, suggesting individuals who carry the Pro allele may have a higher risk to SLE susceptibility than those with the Arg allele. Further studies for replications are needed to confirm that the p53 polymorphism contributes to SLE. Lupus (2005) 14, 842-845.
引用
收藏
页码:842 / 845
页数:4
相关论文
共 17 条
  • [1] Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer
    Biros, E
    Kalina, I
    Kohút, A
    Stubna, J
    Salagovic, J
    [J]. LUNG CANCER, 2001, 31 (2-3) : 157 - 162
  • [2] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [3] The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
    Dumont, P
    Leu, JIJ
    Della Pietra, AC
    George, DL
    Murphy, M
    [J]. NATURE GENETICS, 2003, 33 (03) : 357 - 365
  • [4] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369
  • [5] Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies
    Herkel, J
    Mimran, A
    Erez, N
    Kam, N
    Lohse, AW
    Märker-Hermann, E
    Rotter, V
    Cohen, IR
    [J]. JOURNAL OF AUTOIMMUNITY, 2001, 17 (01) : 63 - 69
  • [6] Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
    Hochberg, MC
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1725 - 1725
  • [7] Systemic lupus erythematosus
    Kotzin, BL
    [J]. CELL, 1996, 85 (03) : 303 - 306
  • [8] p53 codon 72 polymorphism and cervical neoplasia: A meta-analysis review
    Koushik, A
    Platt, RW
    Franco, EL
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (01) : 11 - 22
  • [9] p53 autoantibodies in patients with autoimmune diseases: A quantitative approach
    Kuhn, HM
    Kromminga, A
    Flammann, HT
    Frey, M
    Layer, P
    Arndt, R
    [J]. AUTOIMMUNITY, 1999, 31 (04) : 229 - 235
  • [10] p53, the cellular gatekeeper for growth and division
    Levine, AJ
    [J]. CELL, 1997, 88 (03) : 323 - 331